Navigation Links
VISERA Imaging System

ProductsVISERA Imaging System
Company Olympus America Medical
Item VISERA Imaging System
Features 
  • VISERA allows connection to rigid, flexible and deflectable tip videoscopes, as well as autoclavable camera heads, so there's no need for multiple systems. Both still and moving images are recorded digitally, making them easy to use, store, and manage.
  • Standardized control, simple maintenance, and autoclavable camera heads let staff work comfortably and efficiently.
  • Display a second image simultaneously with the endoscopic image via a number of image display options.
  • Camera-at-the-Tip: Color CCD at the distal end of the endoscope ensures consistent, superb image quality.
  • Expandable to match the needs of surgeons and medical staff by simply adding Build
  • On Demand (BOD) modules (circuit boards) even after the unit has been installed.
Description The VISERA Multi-Specialty Digital Imaging Platform is the world's first integrated system of digital rigid, deflectable tip and flexible videoscopes for use in operating room endosurgery as well as office-based endoscopy procedures.
Info Olympus America Medical
Customer Service: (800) 848-9024
Web site: http://www.olympusamerica.com

Related medicine products :

1. KOWA nonmyd 7 / VK-2 Digital Imaging System
2. KOWA nonmyd a-D / VK-2 Digital Imaging System
3. Genegnome Bio Imaging System for Chemiluminescence
4. Spinal Imaging Platform
5. Sononav Intraoperative Imaging System
6. Stealthstation Siemens Siremobil Iso-C3D C-Arm Imaging System Interface
7. Atlantis SR Pro Coronary Imaging Catheter
8. Galaxy Digital Imaging Console
9. Statscan Critical Imaging System
10. Khosla Slit Lamp Imaging System
11. VISUPAC Fundus Imaging Software
Long handle occluders are approximately 9 inches long....
Basic external reading model....
Manual Lensmeter....
Lightweight, cordless lensmeter....
Medicine Products:
(Date:2/28/2015)... 2015 Plugin creators from Pixel Film ... A fully customizable transition pack made specifically ... gives users total control over 30 transition presets built ... Pixel Film Studios. “TransFold Volume 2 gives endless possibilities ... Volume 2 from Pixel Film Studios brings back folding ...
(Date:2/28/2015)... Angeles, California (PRWEB) February 28, 2015 ... fully supported and showcased emerging brand at Houston ... held in Las Vegas sending its executive delegates ... Director of Business Development and Training Randolph Clarito. ... Association (IFA), was held last February 4-7 and ...
(Date:2/27/2015)... A new study published in the Journal of ... on a regular basis and prostate cancer. While cycling is ... more hours per week a man spends cycling, the more ... increased importance on prostate cancer screening methods. , “This study ... at patents’ risk factors for developing prostate cancer,” says Kia ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 On ... Foundation) and the National Cancer Institute (NCI) will ... at the National Institutes of Health (NIH), in ... part is dedicated to medical professionals and scientists ... directed to the general public, including patients, their ...
(Date:2/27/2015)... San Diego, CA (PRWEB) February 27, 2015 ... Industries’ Vortex-Genie® 2 , price is only valid ... caters to lab technicians looking for a vortex mixer ... , Scientific Industries was founded in 1954 and is ... Vortex-Genie® laboratory mixers & shakers, as well as other ...
Breaking Medicine News(10 mins):Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 3Health News:Pipette.com Announces Limited Time Offer of 24% Off List Price on the Vortex-Genie 2 2
... are more likely to bear an underweight child, but ... because of genetic susceptibility.// The finding could help medicine ... the researchers said they were not recommending at this ... genes involved. ,"Our data demonstrate that a ...
... the UK’s biggest killer, accounting for one in four ... key issue is that the diversity of lung disease ... have specialists who deal only in one disorder, chest ... obstructive pulmonary disorder(COPD), asthma, pneumonia, cystic fibrosis and sleep ...
... team of Swiss researchers found that butterbur extract is ... de Carpentier said,presumably it contains an active biochemical agent,// ... is possible that this might react with other medications. ... researchers gave 154 hayfever patients either butterbur extract tablets ...
... tap water contaminated with chemical byproducts from chlorine. Chlorine ... is added to water that contains organic matter such ... form compounds such as chloroform that can cause illness. ... Group and Public Interest Research Groups identified areas that ...
... more lives each year worldwide if more people at high ... doctors said.// An analysis of nearly 300 clinical trials ... blood clots confirmed that aspirin reduces heart attacks and strokes ... who could benefit from aspirin and anti-platelet therapy receive it. ...
... (sodium hyaluronate), an intra-articular injection that provides relief from ... osteoarthritis. Osteoarthritis is a widely prevalent disease. More than ... 45 are estimated to show signs of this disease, ... people above the age of 65. // ...
Cached Medicine News:
(Date:2/27/2015)...  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... for the fourth quarter and full year ended December ... year for PTC. We are now a growing commercial-stage ... in the rare disease space," stated Stuart W. Peltz, ... proud to bring the first treatment for Duchenne muscular ...
(Date:2/27/2015)... Feb. 27, 2015  Bionik Laboratories Corp. (OTC:DWTPD), a ... today that it acquired Bionik Laboratories, Inc., a ... the sale to qualified accredited investors of units consisting ... proceeds of approximately $6.2 million. Shares of the Company,s ... OTC Markets under the symbol "DWTPD" until FINRA,s approval ...
(Date:2/26/2015)... RnRMarketResearch.com adds Corneal Ulcers ... to its store. This report p provides an ... The report "Corneal Ulcers - Pipeline Review, H2 2014" ... Corneal Ulcers. Corneal Ulcers are primarily result of ... infections & fungal infections. The symptoms of the ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5